CD274 and chordoma: An analysis of 78 chordoma tumor samples revealed a PD-L1 positivity rate of 94.9%, and another study on 58 spinal chordoma samples showed PD-L1 expression in 68.1% of tumors, with a 70.4% expression rate in tumor-infiltrating lymphocytes 22, 23.